Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Immunology

Pathology

Internal Medicine

Surgery

Show all topics

DOI

10.1016/s0140-6736(13)62242-4

License

CC-BY

Other Formats

PDF